ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1584

Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis: A Prospective Cohort Study

Pongchirat Tantayakom1, Ajchara Koolvisoot1, Emvalee Arromdee1, Praveena Chiowchanwisawakit1, Chayawee Muangchan1 and Wanruchada Katchamart2, 1Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Medicine, Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: metabolic syndrome and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid
arthritis (RA) is a chronic systemic inflammatory disease involving articular
and extra-articular systems, including cardiovascular (CVS), respiratory, as
well as hematologic systems, etc. Among extra-articular manifestations, CVS
disease is a leading cause of morbidity and mortality in the recent years. Patients with RA also have increased
risk of metabolic syndrome (MS), compared to general population. Chronic
systemic inflammation from both RA and MS could promote endothelial dysfunction
and atherosclerotic plaques development leading to increase in CVS risk. Our objective was to investigate
the association between MS and disease activity in patients with RA.

Methods:
Siriraj
Rheumatoid Arthritis registry is a prospective cohort study establishing since
May 2011. A total of 267 patients who had complete data in February 2015 were
included in these analyses. All clinical and laboratory data related to disease
activity, functional status, and parameters of MS according to the 2001
National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III)
were collected. For cumulative disease activity, time-adjusted mean (TAM) of disease
activity score (DAS) 28 was calculated. The TAM of DAS28 is the area under a
curve (AUC) of DAS28 plotted against time, divided by the total length of time
from first to last measurement. Univariate and
backward stepwise multivariate analyses were performed to identify factors
associated with MS.

Results: Most (88%) were female with the
mean age ± standard deviation of 59 ± 11.1
years old. MS was found in 43 patients (16%). High blood pressure was the most
prevalent components of MS in both RA with MS and non-MS. Patients with MS had
a significantly lower proportion of patients with remission (time adjusted mean
of disease activity score 28 or DAS28 <
2.6) than those with non-MS (2.3% vs. 16.5%, p = 0.02). Multiple logistic
regression analysis identified 4 independent factors associated with MS
including age [odds ratio (OR) 1.01, 95% confidence
interval (CI) (0.98 to 1.05)], body mass index [OR 1.2, 95% CI 1.1 to 1.3],
educational level ≤ 12 years [OR 5.92, 95% CI 1.47
to 23.83], and disease remission [OR 0.11, 95% CI 0.01 to 0.93]. This model
correctly predicted 84% of cases.

Conclusion:
Disease activity
of RA, body mass index, and educational level are associated with metabolic
syndrome in patients with RA

Table
Odds ratios for
the presence of metabolic syndrome in patients with rheumatoid arthritis

Univariate analysis

Multivariate analysis

OR

95% CI

P value

OR

95% CI

P value

Age

1.02

0.99-1.06

0.14

1.01

0.98-1.05

0.44

Body mass index

1.17

1.09-1.25

< 0.001

1.20

1.1-1.3

< 0.001

Education level ≤ 12 years

3.8

1.3-11.1

0.02

5.92

1.47-23.83

0.01

Rituximab use

9.69

2.22-42.25

0.002

17.44

2.91-104.67

0.002

TAM of DAS28 < 2.6

0.12

0.16-0.90

0.04

0.11

0.01-0.93

0.04

CI
= confidence intervals; OR = odds ratio; TAM = time-adjusted mean; DAS 28=
disease activity score28


Disclosure: P. Tantayakom, None; A. Koolvisoot, None; E. Arromdee, None; P. Chiowchanwisawakit, None; C. Muangchan, None; W. Katchamart, None.

To cite this abstract in AMA style:

Tantayakom P, Koolvisoot A, Arromdee E, Chiowchanwisawakit P, Muangchan C, Katchamart W. Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis: A Prospective Cohort Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/metabolic-syndrome-is-associated-with-disease-activity-in-patients-with-rheumatoid-arthritis-a-prospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/metabolic-syndrome-is-associated-with-disease-activity-in-patients-with-rheumatoid-arthritis-a-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology